Embla Medical

Research Embla Medical (EMBLA.CO) on Bullrun: market cap DKK 12.71B, P/E 20.9. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is DKK 12.71B; P/E is 20.9.

Peer valuation comparison

Latest P/E is 20.87x versus a Healthcare sector median of 24.34x (14.2% below).

Latest P/E is 20.87x versus a Iceland median of 17.42x (19.8% above).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-16DKK 12.71B20.9n/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 DKK.

About Embla Medical

Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics and Neuro Orthotics, Bracing and Supports, and Patient Care. The Prosthetics and Neuro Orthotics segment offers mechanical products, such as lower and upper limb loss or difference; and bionic products, such as microprocessor-controlled feet, knees, hands, fingers, and neuro orthotic joints.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Embla Medical's market cap?

Embla Medical's market capitalization is DKK 12.71B.

What is Embla Medical's P/E ratio?

Embla Medical's price-to-earnings (P/E) ratio is 20.9.

What does Embla Medical do?

Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics and Neuro Orthotics, Bracing and Supports, and Patient Care. The Prosthetics and Neuro Orthotics segment offers mechanical products, such as lower and upper limb loss or difference; and bionic products, such as microprocessor-controlled feet, knees, hands, fingers, and neuro orthotic joints.